Purple Biotech : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
Bonuses 4.2.1. General Terms ... | May 1, 2023
Source: marketscreener.com
📰 Eric Rowinsky News
Eric Rowinsky News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Rowinsky. Real-time updates on events, politics, business and more.
Purple Biotech Reports Temporary Medical Leave of CEO Gil Efron
Board of Directors appoints Isaac Israel, Board member and former CEO, as acting CEOCompany’s business plan and clinical development programs continue as planned REHOVOT, Israel, March 24, 2023 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (
Source: marketscreener.com
Hummingbird Bioscience Holds Opening Ceremony for Singapore Science Park Office and Research Facilities
/PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for...
Eric Rowinsky Heng Swee Keat Jerome Boyd Kirkup Thomasj Lynch Jr Fred Hutchinson Cancer Center National University Health System
Source: prnewswire.com
Purple Biotech Appoints Life Sciences Industry Investor Ori Hershkovitz to its Board of Directors
REHOVOT, Israel, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor
Source: kulr8.com
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies
/PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in...
Source: prnewswire.com
Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies
/PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in...
Source: prnewswire.com
Purple Biotech Appoints Seasoned Biopharmaceutical Industry
Purple Biotech Appoints Seasoned Biopharmaceutical Industry Executive Suzana Nahum-Zilberberg to Board of Directors May 19, 2021 07:00 ET | Source: Purple Biotech Ltd. Purple Biotech Ltd. Tel Aviv, ISRAEL REHOVOT, Israel, May 19, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" ", or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evas...
South Korea Tel Aviv Eric Rowinsky Suzana Nahum Zilberberg Teva Pharmaceuticals Industries Nextferm Technologies Ltd
Source: globenewswire.com
Shanghai Genechem Co., Ltd. (Genechem) Announces appointment of Dr. Eric Rowinsky and Dr. Manuel Hidalgo to Scientific Advisory board, and abstract presentation at AACR 2021 on Claudin 6 Ab and K-Ras TCR-T
Share this article Share this article SHANGHAI, April 8, 2021 /PRNewswire/ -- Shanghai Genechem Co., Ltd. (Genechem), a discovery company dedicated to novel target discovery and development of novel therapeutics, today announced the appointment of Dr. Eric Rowinsky, President and Executive Chairman of the Board of Rgenix, Inc., and Dr. Manuel Hidalgo, Chief of Hematology and Medical Oncology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, to its Scientific Advis...
Source: prnewswire.com